Per Mølstad

Per Mølstad

Auto-generated profile, based on publicly available information

Per Mølstad

Department of Cardiology, LHL Clinics Gardermoen, Jessheim, Norway,

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2012 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
PMPer Mølstad
Per Mølstad
TVTerje Veel
Terje Veel
SRStein Rynning
Stein Rynning
The increasing age in the population and improvements in the treatment options for aortic valvular disease have resulted in a considerable rise in the number of elderly patients being admitted for conventional aortic valve surgery. Recently, transcatheter aortic valve implantation (TAVI) has been developed as a less invasive treatment option. However, both open heart surgery and transcatheter treatment have serious complications. Thus, the knowledge of contemporary results of conventional surgery is important in guiding treatment allocation. From the database at Feiring Heart Clinic, 1525 patients were identified who had undergone aortic valve replacement from 1999 to 2010; of these, 361 patients were more than 80 years of age. The population was followed for all-cause mortality until March 2011, with special reference to the age group older than 80 years and other high-risk subsets. The short-term mortality was 2.2% in the whole population and 3.9% in octogenarians. Five-year survival was 83.1 and 68.1%, respectively. In the high-risk subgroup of patients with a logistic EuroSCORE above 20%, the equivalent figures were 4.2 and 72.7%. Contemporary results after conventional aortic valve surgery are excellent in both short- and long-term survival and should not be withheld in the elderly or otherwise high-risk populations. The logistic EuroSCORE grossly overestimates the operative risk and should be used with caution in allocating patients to TAVI instead of conventional surgery.

1 January 2007 in Scandinavian Cardiovascular Journal
Verified
Journal Article
Closed access
PMPer Mølstad
Per Mølstad
Comparison of survival after percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in patients with coronary disease.Feiring Heart Clinic treated 10 815 patients with a coronary intervention (6366 PCI, 4449 CABG) from March 1999 to December 31, 2005. Their survival status as of May 31, 2006 was ascertained through the Norwegian National Registry. Survival in PCI and CABG cohorts was compared using Cox regression and propensity analysis.. Covariate adjusted survival was significantly improved by CABG compared to PCI in patients with three vessel disease with and without diabetes, with hazard ratios of 0.40 and 0.61, respectively. The difference was of borderline significance in patients with one/two vessel disease with diabetes, and no difference in survival between the strategies in patients with one/two vessel disease without diabetes. Propensity analysis supported these observations. Improved survival for the PCI cohort was observed in the last quintile of procedure times.Patients with three vessel disease with or without diabetes seem to have a survival benefit with CABG compared to PCI treatment.

24 October 2016 in Open Heart
Verified
Journal Article
Open access
PDF file
PMPer Mølstad
Per Mølstad
RMRasmus Moer
Rasmus Moer
OROlaf Rødevand
Olaf Rødevand
Objectives To assess whether there exists a long-term difference in survival after treatment with coronary bypass surgery or percutaneous coronary intervention in patients with coronary disease as judged by all-cause mortality. Methods Retrospective study from the Feiring Heart Clinic database of survival in 22 880 patients—15 078 treated with percutaneous coronary intervention and 7802 with bypass surgery followed up to 16 years. Results Cox regression and propensity score analysis showed no difference in survival for one-vessel and two-vessel disease during the whole study period. In three-vessel disease, however, the analysis revealed a consistent and highly significant survival benefit in the first 8 years with an HR of 0.76 (95% CI 0.69 to 0.84, p<0.001) in favour of bypass surgery with similar survival rates in the two treatment strategies after that time period. Conclusions Treatment strategy did not affect survival in one-vessel and two-vessel disease, but bypass surgery offered an improved survival in the first 8 years in patients with three-vessel disease. These results are consistent with most previous reports and the survival benefit should be taken into account when selecting a strategy for this patient group.

1 January 2009 in Scandinavian Cardiovascular Journal
Verified
Journal Article
Open access
PMPer Mølstad
Per Mølstad
The aim of the study was to compare extent of coronary disease and subsequent long-term survival in women compared to men adjusted for baseline differences in demographics and morbidity. In the database at Feiring Heart Clinic 18 767 patients had a coronary angiographic examination in the period from March 1999 to December 31, 2006. Their survival status as of May 31, 2007 was ascertained through the Norwegian National Registry. Survival was compared using age stratified analyses and Cox regression adjusting for baseline differences. Significantly more women than men had no coronary disease (28.7 vs. 10.5%, p <0.001), while three vessel disease was more frequently present in men (38.7 vs. 21.8%, p <0.001), as judged by coronary angiography. Covariate adjusted survival was significantly better in women compared to men with an overall hazard ratio of 1.29 (p <0.001), but with no significant difference in the subgroup with high left ventricular end diastolic pressure. At the time of referral to invasive examination women had less extensive coronary artery disease than men as judged by coronary angiography and improved long-term survival when baseline differences were accounted for.

1 January 1991 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
PMP. Mølstad
P. Mølstad
MAM. Abdelnoor
M. Abdelnoor
The use of digitalis in patients who have sustained an acute myocardial infarction has been controversial. A number of reports have suggested that the use of the glucoside actually can increase mortality. In all previous reports, digoxin has been the glucoside in use. In 620 patients admitted to Hamar Hospital from January 1, 1982 to December 31, 1984 with an acute myocardial infarction, 159 were using digitoxin at entry. Their survival until January 1, 1985 was compared with the rest of the population, not using digitoxin. The patients on digitoxin had a significantly higher mortality than those who were not, with a relative risk ratio of 2.33. However, major differences in baseline risk factors existed, and a multivariate Cox regression analysis was employed to adjust for the inequalities in baseline covariates. Only variables available at the entry of the index infarction were used for adjustment. Serum sodium, serum creatinine, age and no smoking were identified in a backward selection procedure as independently influencing mortality. By adjusting for these variables the relative risk ratio was reduced to 1.41, but digitoxin still exerted a significant influence on mortality. It is concluded that the results obtained with the use of digitoxin during a myocardial infarction is similar to previous reports with digoxin. Most of the excess mortality in the digitoxin group can be accounted for by inequalities in baseline characteristics. However, the possibility that a small excess in mortality is due to the digitalis glucoside cannot be excluded.

1 January 2007 in Scandinavian Cardiovascular Journal
Verified
Journal Article
Closed access
PMPer Mølstad
Per Mølstad
The aim of the present study was to compare the extent of coronary disease and subsequent survival in diabetics and non-diabetics. From the database at Feiring Heart Clinic 13511 patients were identified with no previous revascularization and were examined with coronary angiography in the period from March 1999 to December 31, 2005. In the cohort 1,475 patients were diabetics. Their survival status of May 31, 2006 was ascertained through the Norwegian National Registry. Diabetics were more symptomatic and had a more severe coronary artery disease at the time of referral with more than 40% having three vessel disease. The unadjusted survival was lower in the diabetics. After adjustment through Cox regression, diabetes mellitus remained a risk factor for subsequent death (overall hazard ratio 1.33), with the excess mortality mainly residing in smoking diabetics. Diabetics were more severely diseased at the time of referral. In Cox regression diabetes mellitus remained a significant risk factor for death in smokers except in the cohort treated with CABG.